111In-pentetreotide scintigraphy: Procedure guidelines for tumour imaging

Emilio Bombardieri, Valentina Ambrosini, Cumali Aktolun, Richard P. Baum, Angelica Bishof-Delaloye, Silvana Del Vecchio, Lorenzo Maffioli, Luc Mortelmans, Wim Oyen, Giovanna Pepe, Arturo Chiti

Research output: Contribution to journalArticle

Abstract

This document provides general information about somatostatin receptor scintigraphy with 111In-pentetreotide. This guideline should not be regarded as the only approach to visualise tumours expressing somatostatin receptors or as exclusive of other nuclear medicine procedures useful to obtain comparable results. The aim of this guideline is to assist nuclear medicine physicians in recommending, performing, reporting and interpreting the results of 111In-pentetreotide scintigraphy.

Original languageEnglish
Pages (from-to)1441-1448
Number of pages8
JournalEuropean Journal of Nuclear Medicine and Molecular Imaging
Volume37
Issue number7
DOIs
Publication statusPublished - Jul 2010

Keywords

  • In-pentetreotide scintigraphy
  • Indications
  • Neuroendocrine tumours
  • Procedure guidelines
  • Tumour imaging

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint Dive into the research topics of '<sup>111</sup>In-pentetreotide scintigraphy: Procedure guidelines for tumour imaging'. Together they form a unique fingerprint.

  • Cite this

    Bombardieri, E., Ambrosini, V., Aktolun, C., Baum, R. P., Bishof-Delaloye, A., Del Vecchio, S., Maffioli, L., Mortelmans, L., Oyen, W., Pepe, G., & Chiti, A. (2010). 111In-pentetreotide scintigraphy: Procedure guidelines for tumour imaging. European Journal of Nuclear Medicine and Molecular Imaging, 37(7), 1441-1448. https://doi.org/10.1007/s00259-010-1473-6